Nautilus Biotechnology In... (NAUT)
NASDAQ: NAUT
· Real-Time Price · USD
0.73
0.03 (4.29%)
At close: May 12, 2025, 10:30 AM
4.29% (1D)
| Bid | 0.69 |
| Market Cap | 92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -68.66M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -1.35 |
| Forward PE | -0.99 |
| Analyst | Hold |
| Ask | 0.92 |
| Volume | 52,624 |
| Avg. Volume (20D) | 159,390 |
| Open | 0.75 |
| Previous Close | 0.70 |
| Day's Range | 0.70 - 0.75 |
| 52-Week Range | 0.66 - 3.09 |
| Beta | 1.23 |
About NAUT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAUT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAUT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-18.18%
Nautilus Biotechnology shares are trading lower. T...
Unlock content with
Pro Subscription
10 months ago
+2.7%
Nautilus Biotechnology shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and a $6 price target.
2 months ago · seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call TranscriptNautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Exe...